TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32717045

Group type: EXPERIMENTAL
Intervention: Once-daily FDC antihypertensive pill (telmisartan, 20 mg; amlodipine, 2.5 mg; chlorthalidone, 12.5 mg)
Number of subjects: 700

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 700
Study: 33478495

Group type: EXPERIMENTAL
Intervention: START app
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: START app features (entering daily step counts, reminders, motivational messages)
Number of subjects: 50
Study: 33164553

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 3730
Study: 35139832

Group type: EXPERIMENTAL
Intervention: Telenursing training based on family-centered empowerment pattern
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study: 34580947

Group type: EXPERIMENTAL
Intervention: Combination of maternal risk factors, mean arterial pressure (MAP), serum placental growth factor (PlGF), and serum soluble fms-like tyrosine kinase-1 (sFLT-1) (triple test)
Number of subjects: 29677

Group type: EXPERIMENTAL
Intervention: Triple test (without UtA-PI)
Number of subjects: 29677
Study: 34269974

Group type: EXPERIMENTAL
Intervention: Sodium iron EDTA (NaFeEDTA) salt-enriched fish powder (250 mg/100 g)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 123
Study: 34980184

Group type: EXPERIMENTAL
Intervention: Intranasal ketamine (0.75 mg/kg, max 75 mg)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Intravenous ketorolac (30 mg)
Number of subjects: 140
Study: 32769754

Group type: EXPERIMENTAL
Intervention: Remote ophthalmology attending feedback
Number of subjects: 10

Group type: COMPARATOR
Intervention: No remote feedback
Number of subjects: 10
Study: 35195012

Group type: EXPERIMENTAL
Intervention: Immediate coronary angiography
Number of subjects: 538

Group type: COMPARATOR
Intervention: Delayed coronary angiography
Number of subjects: 538
Study: 34139047

Group type: EXPERIMENTAL
Intervention: MM - mechanical debridement + metronidazole-minocycline ointment
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: MC - mechanical debridement + minocycline ointment
Number of subjects: 114

Group type: COMPARATOR
Intervention: NST - mechanical debridement only
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: MM
Number of subjects: 114
Study: 32444567

Group type: EXPERIMENTAL
Intervention: Restricted fluid management for the first 72 hours
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard fluid management for the first 72 hours
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Restricted fluid management
Number of subjects: 100
Study: 36162865

Group type: EXPERIMENTAL
Intervention: Peer support program in Uganda and Sweden
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Care companion in South Africa
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Community-facility link
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Continuous capacity building
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall implementation process
Number of subjects: 0
Study: 32522073

Group type: EXPERIMENTAL
Intervention: ESBL-producing E. coli isolates
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: PFGE types
Number of subjects: 216
Study: 34353650

Group type: EXPERIMENTAL
Intervention: Ketamine (5 mg/kg intramuscular injection)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Midazolam and Haloperidol (5 mg midazolam and 5 mg haloperidol intramuscular injection)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Midazolam and Haloperidol
Number of subjects: 80
Study: 32334141

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 734
Study: 33921381

Group type: EXPERIMENTAL
Intervention: Average ambient temperature between 0 and 10 °C
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Random forest statistical model
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Population age, temperature, and international tourism
Number of subjects: 154
Study: 32158186

Group type: EXPERIMENTAL
Intervention: Apatinib (500 mg on a 4-week cycle)
Number of subjects: 32
Study: 36163892

Group type: EXPERIMENTAL
Intervention: Ibrutinib 420 mg once-daily until disease progression or unacceptable toxicity (n=136)
Number of subjects: 269

Group type: COMPARATOR
Intervention: Chlorambucil 0.5-0.8 mg/kg for ≤12 cycles (n=133)
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Ibrutinib 420 mg once-daily
Number of subjects: 269
Study: 34212534

Group type: EXPERIMENTAL
Intervention: IHC/histology-based classifier integrating NRP1, RGS5, FOXM1, and tumour necrosis
Number of subjects: 342

Group type: COMPARATOR
Intervention: ClearCode34 classifier
Number of subjects: 342
Study: 32283727

Group type: EXPERIMENTAL
Intervention: Implementation intention condition
Number of subjects: 66

Group type: COMPARATOR
Intervention: Goal condition
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Mind-over-body beliefs
Number of subjects: 66
Study: 36247079

Group type: EXPERIMENTAL
Intervention: Normal saline 0.9% solution for nasopharyngeal wash
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Comparison between normal saline and control
Number of subjects: 50
Study: 34152880

Group type: EXPERIMENTAL
Intervention: Topical Lawsonia inermis L. (Henna) hydrogel (H.gel) applied four times a day for 2 weeks
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo applied four times a day for 2 weeks
Number of subjects: 18
Study: 34753776

Group type: EXPERIMENTAL
Intervention: HE-MACS score
Number of subjects: 629

Group type: EXPERIMENTAL
Intervention: HEAR score
Number of subjects: 629
Study: 32662827

Group type: COMPARATOR
Intervention: Mechanical brushing (MB; brush and dentifrice, control)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: MB with oral irrigation (Waterpik [WP], experimental)
Number of subjects: 38
Study: 35853672

Group type: EXPERIMENTAL
Intervention: Sleep First Group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Wake First Group
Number of subjects: 40
Study: 34531216

Group type: EXPERIMENTAL
Intervention: Yoga-based programme, 1 hour per day for 6 days a week, for 24 weeks
Number of subjects: 250

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 250
Study: 34966120

Group type: EXPERIMENTAL
Intervention: Neuromuscular Electrical Stimulation (NMES) treatment, 4 sessions over 2 weeks
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 26
Study: 32218302

Group type: EXPERIMENTAL
Intervention: 12 weeks TDM (The Daily Mile)
Number of subjects: 659

Group type: EXPERIMENTAL
Intervention: 12 weeks TDM + additional personal support
Number of subjects: 659

Group type: COMPARATOR
Intervention: Control (no TDM)
Number of subjects: 659
Study: 35940873

Group type: EXPERIMENTAL
Intervention: Low dose intravenous paracetamol (10 mg/kg/dose 6 hourly for 72 hours)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Conventional dose intravenous paracetamol (15 mg/kg/dose 6 hourly for 120 hours)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Both groups (Low dose and Conventional dose)
Number of subjects: 102
Study: 34351205

Group type: EXPERIMENTAL
Intervention: Concurrent expert testimony
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Adversarial expert testimony
Number of subjects: 93

Group type: COMPARATOR
Intervention: Court-appointed expert testimony
Number of subjects: 93
Study: 32443036

Group type: EXPERIMENTAL
Intervention: Pancreatic enzyme replacement therapy (PERT) with 2000 U lipase/kg/day in 4 doses plus hypercaloric enteral supplements
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group received hypercaloric enteral supplements only
Number of subjects: 40
Study: 35317771

Group type: EXPERIMENTAL
Intervention: Digital storytelling method (n = 33)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional method (n = 33)
Number of subjects: 60
Study: 34845204

Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonsurgical diabetes/weight management
Number of subjects: 0
Study: 32251360

Group type: EXPERIMENTAL
Intervention: L-dopa/benserazide 100/25 mg
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 34981829

Group type: EXPERIMENTAL
Intervention: Secukinumab 300 mg every 2 weeks (Q2W)
Number of subjects: 331

Group type: COMPARATOR
Intervention: Secukinumab 300 mg every 4 weeks (Q4W)
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Uptitration to Q2W from Q4W
Number of subjects: 331
Study: 33972238

Group type: EXPERIMENTAL
Intervention: Combination of amikacin and fosfomycin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standard fosfomycin-amikacin neonatal regimen
Number of subjects: 0
Study: 32319233

Group type: EXPERIMENTAL
Intervention: SCR followed by 6 cycles of platinum-based chemotherapy and niraparib maintenance
Number of subjects: 96

Group type: COMPARATOR
Intervention: 6 cycles of platinum-based chemotherapy and niraparib maintenance alone
Number of subjects: 96
Study: 36205312

Group type: EXPERIMENTAL
Intervention: Species‐Specific Bacterial Detector (SSBD)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Traditional cultivation method
Number of subjects: 77
Study: 35194453

Group type: EXPERIMENTAL
Intervention: MTX + letrozole
Number of subjects: 90

Group type: COMPARATOR
Intervention: MTX + placebo
Number of subjects: 90
Study: 35695264

Group type: EXPERIMENTAL
Intervention: TTM at 33°C
Number of subjects: 171

Group type: COMPARATOR
Intervention: TTM at 36°C
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Elevated miR-9-3p levels at 48h
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: miR-9-3p
Number of subjects: 171
Study: 35408245

Group type: EXPERIMENTAL
Intervention: 3D VR task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2D screen task
Number of subjects: 0

Group type: COMPARATOR
Intervention: no task eyes open state
Number of subjects: 0
Study: 32147084

Group type: EXPERIMENTAL
Intervention: Eurhythmy Therapy (EYT)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 80
Study: 32989920

Group type: EXPERIMENTAL
Intervention: Filgotinib (200 mg once daily for 15 days)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Levonorgestrel (150 μg)/Ethinyl Estradiol (30 μg) alone (reference)
Number of subjects: 24
Study: 32079428

Group type: EXPERIMENTAL
Intervention: Shimian granules (SMG) 10.0 g orally 2 times daily for 1 month
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 36152871

Group type: EXPERIMENTAL
Intervention: mpMRI
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: mpMRI PSAD
Number of subjects: 640

Group type: COMPARATOR
Intervention: TRUS PSAD
Number of subjects: 640

Group type: COMPARATOR
Intervention: TRUS
Number of subjects: 640
Study: 33462851

Group type: EXPERIMENTAL
Intervention: Bayesian adaptive design using a multiarmed bandit framework
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thompson sampling for treatment allocation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hierarchical model for individual and population treatment effects
Number of subjects: 0
Study: 32612355

Group type: EXPERIMENTAL
Intervention: WB‐EMS & Protein Supplement
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Protein Supplement
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: N-terminal prohormone of brain natriuretic peptide (NT-proBNP)
Number of subjects: 100
Study: 34107708

Group type: EXPERIMENTAL
Intervention: Warming acupuncture and moxibustion at temples combined with Deanxit
Number of subjects: 252

Group type: COMPARATOR
Intervention: Routine group (control)
Number of subjects: 252
Study: 32057570

Group type: EXPERIMENTAL
Intervention: BCG vaccination at birth (Danish strain 1331, Statens Serum Institut)
Number of subjects: 300

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 300
Study: 34774669

Group type: EXPERIMENTAL
Intervention: RS2-enriched wheat flour
Number of subjects: 30

Group type: COMPARATOR
Intervention: wild-type flour
Number of subjects: 30
Study: 34723652

Group type: EXPERIMENTAL
Intervention: Anti-activin A antibody
Number of subjects: 0

Group type: COMPARATOR
Intervention: Elevated activin A, activin B, and FLRG at hospital admission
Number of subjects: 0
Study: 36029208

Group type: EXPERIMENTAL
Intervention: Dexamethasone therapy for 19 days
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Dexamethasone therapy
Number of subjects: 85
Study: 32960329

Group type: COMPARATOR
Intervention: cTACE (conventional transarterial chemoembolization)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: DSM-TACE (drug-eluting beads transarterial chemoembolization)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: DSM-TACE
Number of subjects: 50

Group type: COMPARATOR
Intervention: cTACE
Number of subjects: 50
Study: 33263237

Group type: EXPERIMENTAL
Intervention: Stainless steel wire fixation and BM injection at the fracture line
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Plate fixation and BM injection at the fracture line
Number of subjects: 30

Group type: COMPARATOR
Intervention: Stainless steel bone wire fixation and placebo saline injection at the fracture line
Number of subjects: 30

Group type: COMPARATOR
Intervention: Plate fixation and placebo injection at the fracture line
Number of subjects: 30
Study: 34727202

Group type: EXPERIMENTAL
Intervention: Polyphenol-enriched diet
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 51
Study: 33637625

Group type: EXPERIMENTAL
Intervention: PENG block
Number of subjects: 60

Group type: COMPARATOR
Intervention: FNB
Number of subjects: 60
Study: 35963959

Group type: COMPARATOR
Intervention: Ropanicant (SUVN-911) single doses (0.5, 6, 15, 30, and 60 mg) and multiple doses (15, 30, and 45 mg) administered orally for 14 days.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ropanicant (30 mg) administered orally in Study 2.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ropanicant (multiple doses) administered orally.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ropanicant (various doses) administered orally.
Number of subjects: 0
Study: 33681893

Group type: COMPARATOR
Intervention: TAC+MMF+PRED (cohort 1)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: EVL+MMF+PRED (cohort 2)
Number of subjects: 97
Study: 33819495

Group type: EXPERIMENTAL
Intervention: 1-mg granisetron
Number of subjects: 0

Group type: COMPARATOR
Intervention: 3-mg granisetron
Number of subjects: 0
Study: 33833278

Group type: EXPERIMENTAL
Intervention: Partial-body cryostimulation (PBC) - 3 minutes at -150 °C
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control condition - 3 minutes at room temperature (20 °C)
Number of subjects: 18
Study: 36070920

Group type: EXPERIMENTAL
Intervention: Dual antiplatelet therapy (DAPT) using cilostazol
Number of subjects: 1878

Group type: COMPARATOR
Intervention: Monotherapy (aspirin or clopidogrel alone)
Number of subjects: 1878
Study: 33616815

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI) for patients only (Arm 1)
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI) for patients and caregivers (Arm 2)
Number of subjects: 510

Group type: COMPARATOR
Intervention: Standard treatment (Arm 3)
Number of subjects: 510
Study: 35777693

Group type: EXPERIMENTAL
Intervention: Left atrial appendage closure in addition to elective open-heart surgery
Number of subjects: 186

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 186
Study: 34350536

Group type: EXPERIMENTAL
Intervention: Extended depth of focus (EDF) contact lenses
Number of subjects: 17

Group type: COMPARATOR
Intervention: Single-vision (SV) contact lenses
Number of subjects: 17
Study: 36400089

Group type: EXPERIMENTAL
Intervention: Influenza vaccine (0.5 ml intramuscularly once a year for up to 3 years)
Number of subjects: 5129

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 5129
Study: 32185143

Group type: EXPERIMENTAL
Intervention: DNA extraction with classical mechanical and chemical cell disruption
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DNA extraction with specific pre‐treatments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Frozen storage for up to 1 year
Number of subjects: 0
Study: 35999527

Group type: EXPERIMENTAL
Intervention: NEPA and DEX (12 mg) on day 1, no further DEX (DEX1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NEPA and DEX (12 mg) on day 1, oral DEX (4 mg daily) on days 2-3 (DEX3)
Number of subjects: 0

Group type: COMPARATOR
Intervention: DEX (4 mg twice daily) on days 2-4 (DEX4; control)
Number of subjects: 0
Study: 33964430

Group type: EXPERIMENTAL
Intervention: Intravenous tranexamic acid (TXA) 1 g plus 100 mL saline
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo group (100 mL saline)
Number of subjects: 96
Study: 32470241

Group type: EXPERIMENTAL
Intervention: RF powered toothbrush
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control powered toothbrush
Number of subjects: 85
Study: 35450161

Group type: EXPERIMENTAL
Intervention: Moderate walking thrice weekly (MOD × 3/week)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vigorous walking thrice weekly (VIG × 3/week)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Moderate walking once weekly (MOD × 1/week)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vigorous walking once weekly (VIG × 1/week)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Attention control (CON)
Number of subjects: 0
Study: 33594600

Group type: EXPERIMENTAL
Intervention: Strains BR 10788 and BR 11793
Number of subjects: 877

Group type: EXPERIMENTAL
Intervention: Strains with antagonistic effects
Number of subjects: 877
Study: 36030400

Group type: EXPERIMENTAL
Intervention: Double-dose quadrivalent inactivated vaccine before hospital discharge
Number of subjects: 1801

Group type: COMPARATOR
Intervention: Standard-dose quadrivalent inactivated vaccine administered in the outpatient setting 30 days after randomization
Number of subjects: 1801
Study: 33848441

Group type: EXPERIMENTAL
Intervention: Vibrating Mesh Nebulizer (VMN) with salbutamol (2.5 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Jet Nebulizer (JN) with salbutamol (2.5 mg)
Number of subjects: 30
Study: 33064669

Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Etamsylate
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study: 32023524

Group type: EXPERIMENTAL
Intervention: smartphone mobile app
Number of subjects: 181

Group type: COMPARATOR
Intervention: standard care
Number of subjects: 181
Study: 35666933

Group type: EXPERIMENTAL
Intervention: Survivors of sex trafficking (ST)
Number of subjects: 1264

Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 1264

Group type: EXPERIMENTAL
Intervention: Female sex
Number of subjects: 1264

Group type: EXPERIMENTAL
Intervention: Employment
Number of subjects: 1264

Group type: EXPERIMENTAL
Intervention: Better social relationships
Number of subjects: 1264
Study: 35028158

Group type: EXPERIMENTAL
Intervention: Cervical collar
Number of subjects: 0

Group type: COMPARATOR
Intervention: No collar
Number of subjects: 0
Study: 32273696

Group type: EXPERIMENTAL
Intervention: Ginseng capsules (200 mg, twice per day)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 36175099

Group type: EXPERIMENTAL
Intervention: Volunteer peer health and well-being coaching
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 33751924

Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo-PBMT
Number of subjects: 53
Study: 35088549

Group type: EXPERIMENTAL
Intervention: WMEN diet
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 35% calorie-reduced diet
Number of subjects: 50

Group type: COMPARATOR
Intervention: Food insecurity
Number of subjects: 50
Study: 33563735

Group type: EXPERIMENTAL
Intervention: Local anesthesia lidocaine hydrochloride 2% in group A
Number of subjects: 60

Group type: COMPARATOR
Intervention: Systemic analgesia intravenous tramadol chloride 100 mg in group B
Number of subjects: 60
Study: 32711689

Group type: EXPERIMENTAL
Intervention: Brief lay counsellor-delivered, problem-solving intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 34879374

Group type: EXPERIMENTAL
Intervention: Drug-Eluting Stents (DES)
Number of subjects: 6251

Group type: COMPARATOR
Intervention: Bare-Metal Stents (BMS)
Number of subjects: 6251

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 6251
Study: 32219442

Group type: EXPERIMENTAL
Intervention: Venetoclax plus LDAC
Number of subjects: 211

Group type: COMPARATOR
Intervention: LDAC alone
Number of subjects: 211
Study: 35201540

Group type: EXPERIMENTAL
Intervention: Placement into the homes of trained, supported foster parents
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Attachment and Biobehavioral Catch‐up intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Orphanage care
Number of subjects: 0
Study: 34433679

Group type: EXPERIMENTAL
Intervention: EDSS
Number of subjects: 1008

Group type: EXPERIMENTAL
Intervention: T25FW
Number of subjects: 1008

Group type: EXPERIMENTAL
Intervention: NHPT
Number of subjects: 1008

Group type: COMPARATOR
Intervention: Kaplan-Meier method
Number of subjects: 1008
Study: 32740183

Group type: EXPERIMENTAL
Intervention: Formal nutrition curriculum (delivered in 95% of programs, 19/20)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Self-reported fellow comfort with nutrition topics
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Responsibility for writing daily parenteral nutrition prescriptions
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Comfort in providing parenteral nutrition support
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Perceived effectiveness of nutritional curriculum
Number of subjects: 95
Study: 32212483

Group type: EXPERIMENTAL
Intervention: L-carnitine (1g, tid) for 3 months
Number of subjects: 240

Group type: COMPARATOR
Intervention: Vitamin E (100 mg, tid) for 3 months (Control)
Number of subjects: 240
Study: 616683729

Group type: EXPERIMENTAL
Intervention: Expressive writing intervention (details not specified)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (details not specified)
Number of subjects: 48